Wednesday, June 29th, 2022

Tag: cell and gene therapy bioassay services

The Market is Expected to Grow at an Annualized Rate of ~30%

Stringent regulatory guidelines pertaining to cell and gene therapies has made it mandatory for developer companies to conduct extensive preclinical and clinical research to generate the necessary body of evidence, validating the safety, efficacy...

COMPETITIVE EDGE, STAKEHOLDERS ARE ACTIVELY EXPANDING

The primary purpose of this analysis was to develop a deeper understanding of the overall strength of the contract service providers involved in this field. It allows companies to compare their existing capabilities within...

Industry Stakeholders and ResearchersExpanding their Existing Infrastructure and Capabilities

  In the pharmaceutical industry, stakeholders are known to adopt a variety partnership models. Such initiatives not only allow the companies to expand their respective product / therapy, but also to gain additional capabilities...

The projected market opportunity is anticipated to be well-distributed

As per our research, digital therapeutic solutions for metabolic disorders are likely to capture major share (XX%) of the overall market in 2020. This can be attributed to the fact that majority of the...

The Market is Expected to Grow at an Annualized Rate of ~30%

Stringent regulatory guidelines pertaining to cell and gene therapies has made it mandatory for developer companies to conduct extensive preclinical and clinical research to generate the necessary body of evidence, validating the safety, efficacy...